To require the Comptroller General to review medical research and development sponsored by the Department of Defense relating to improved combat casualty care and saving lives on the battlefield.

1. Adds SEC. 1080. COMPTROLLER GENERAL REVIEW OF MEDICAL RESEARCH AND DEVELOPMENT RELATING TO IMPROVED COMBAT CASUALTY CARE at the end of subtitle G of title X

   Adds a section

   In S. 1867 · Placed on Calendar Senate

   (c) Authorization of Appropriations.--Of the amounts authorized to be appropriated under section 301 for operation and maintenance for Defense-wide activities, up to $1,000,000, shall be made available for the completion of the study required under this section.

   Inserted: SEC. 1080. COMPTROLLER GENERAL REVIEW OF MEDICAL RESEARCH AND DEVELOPMENT RELATING TO IMPROVED COMBAT CASUALTY CARE.

   Inserted: (a) Study Required.--The Comptroller General of the United States shall conduct a review of Department of Defense programs and organizations related to, and resourcing of, medical research and development in support of improved combat casualty care designed to save lives on the battlefield.

   Inserted: (b) Report.--Not later than January 1, 2013, the Comptroller General shall submit to the congressional defense committees a report on the review conducted under subsection (a), including the following elements:

   Inserted: (1) A description of current medical combat casualty care research and development programs throughout the Department of Defense, including basic and applied medical research, technology development, and clinical research.

   Inserted: (2) An identification of organizational elements within the Department that have responsibility for planning and oversight of combat casualty care research and development.

   Inserted: (3) A description of the means by which the Department applies combat casualty care research findings, including development of new medical devices, to improve battlefield care.

   Inserted: (4) An assessment of the adequacy of the coordination by the Department of planning for combat casualty care medical research and development and whether or not the Department has a coordinated combat casualty care research and development strategy.

   Inserted: (5) An assessment of the adequacy of resources provided for combat casualty care research and development across the Department.

   Inserted: (6) An assessment of the programmatic, organizational, and resource challenges and gaps faced by the Department in optimizing investments in combat casualty care medical research and development in order to save lives on the battlefield.

   Inserted: (7) The extent to which the Department utilizes expertise from experts and entities outside the Department with expertise in combat casualty care medical research and development.

   Inserted: (8) An assessment of the challenges faced in rapidly applying research findings and technology developments to improved battlefield care.

   Inserted: (9) Recommendations regarding--

   Show 3 more inserted paragraphsShow less

   Inserted: (A) the need for a coordinated combat casualty care medical research and development strategy;

   Inserted: (B) organizational obstacles or realignments to improve effectiveness of combat casualty care medical research and development; and

   Inserted: (C) adequacy of resource support.

   Original wording

   At the end of subtitle G of title X, add the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed